# Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML

> **NCT00606723** · PHASE3 · COMPLETED · sponsor: **Hannover Medical School** · enrollment: 154 (actual)

## Conditions studied

- Acute Myeloid Leukemia (AML)

## Interventions

- **BIOLOGICAL:** Hematopoietic stem cells from bone marrow or peripheral blood

## Key facts

- **NCT ID:** NCT00606723
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2021-02-24
- **Final completion:** 2021-02-24
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00606723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00606723, "Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00606723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*